ASC42 received Fast Track designation from the US FDA for NASH... Dec 28
The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard... Dec 28
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
-Advertisements-